During the past decade, Brisbane Clinic for Lymphoma, Myeloma and Leukaemia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Brisbane Clinic for Lymphoma, Myeloma and Leukaemia" are "B-cell Lymphoid Malignancies" (1 trials), "B-cell Malignancies" (1 trials), "Lymphoma" (1 trials) and "Non Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Brisbane Clinic for Lymphoma, Myeloma and Leukaemia" in a lesser frequency.

Most popular intervention types in "Brisbane Clinic for Lymphoma, Myeloma and Leukaemia" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Zanubrutinib" (2 trials), "Obinutuzumab" (1 trials), "RP4010" (1 trials), "Tenalisib," (1 trials) and "Tislelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brisbane Clinic for Lymphoma, Myeloma and Leukaemia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Brisbane Clinic for Lymphoma, Myeloma and Leukaemia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Brisbane Clinic for Lymphoma, Myeloma and Leukaemia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brisbane Clinic for Lymphoma, Myeloma and Leukaemia, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".